Remove companies abbott-laboratories
article thumbnail

Abbott Says Ex-Nutrition Scientist Is Peddling Trade Secrets

Law 360

Abbott Laboratories has accused a former nutrition scientist of taking thousands of confidential documents with him when he left the company, claiming that he's now hawking those trade secrets to Abbott's competitors, according to a suit filed in Illinois federal court.

Court 97
article thumbnail

Baby Formula Manufacturer Abbott Laboratories Under DOJ Investigation

The Crime Report

Abbott Laboratories, the multinational healthcare company, is under investigation by the Department of Justice, Laura Stickler reports for NBC News. Abbott decided to shut down production at its Sturgis infant formula manufacturing plant in February 2022 after infants who consumed formula made at the plant became sick.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Abbott Says It Is Not Implicated In Baby Formula MDL

Law 360

Abbott Laboratories says it is not directly implicated in multidistrict litigation over an infant formula shortage that led people to spend more time searching for formula and paying more when they found it because Abbott's alleged actions benefited third-party resellers, as opposed to the company itself.

article thumbnail

Abbott Units Beat Consultant's Training Copyright Suit

Law 360

Three Abbott Laboratories units have broken free from a copyright suit in California federal court lodged by an operations consultant that claimed the companies made knockoffs of its training materials for engineers.

Court 40
article thumbnail

Religious liberty and patent validity

SCOTUSBlog

Upon denial of Apple’s prior petitions, the company sought to argue that these denials were unlawful because the NHK- Fintiv Rule, used to justify them, exceeds the PTO’s authority under the Leahy-Smith America Invents Act. Abbott Laboratories P.R., González-Bermúdez v.

article thumbnail

Compulsory Licensing Of Drugs and Vaccines in the Backdrop Of The Pandemic: Pros and Cons.

LexForti

Specifically, both sought to procure and provide efavirenz (marketed as Sustiva by Merck) and lopinavir /ritonavir (marketed as Kaletra by AbbVie, then Abbott Laboratories) to their patients. For instance, Abbott withdrew its products from Thailand after imposition of a compulsory license.